Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Tempest Therapeutics Inc (TPST)

Tempest Therapeutics Inc (TPST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tempest Therapeutics Inc 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 USA

www.tempesttx.com Employees: 17 P: 415-798-8589

Description:

Tempest Therapeutics Inc. is a clinical-stage oncology company developing potentially first-in-class therapeutics which combines both targeted and immune-mediated mechanisms. Tempest Therapeutics Inc., formerly known as Millendo Therapeutics Inc., is based in Calif.

Key Statistics

Overview:

Market Capitalization, $K 22,924
Enterprise Value, $K -10,046
Shares Outstanding, K 25,208
Annual Sales, $ 0 K
Annual Net Income, $ -29,490 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -9,570 K
EBIT, $ -31,650 K
EBITDA, $ -31,270 K
60-Month Beta -1.78
% of Insider Shareholders 3.27%
% of Institutional Shareholders 22.52%
Float, K 24,384
% Float 96.73%
Short Volume Ratio 0.53

Growth:

1-Year Return -74.43%
3-Year Return -91.79%
5-Year Return -99.21%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.28%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.42 on 08/08/24
Next Earnings Date 11/13/24
Earnings Per Share ttm -1.60
EPS Growth vs. Prev Qtr -16.67%
EPS Growth vs. Prev Year 22.22%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 06/28/21

TPST Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -201.10%
Return-on-Assets % -78.32%
Profit Margin % 0.00%
Debt/Equity 0.12
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.13
Book Value/Share 0.81
Interest Coverage -19.34
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar